Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
José R. Banegas(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Fernando Rodríguez‐Artalejo(Universidad Autónoma de Madrid), Esther López‐García(Hospital Universitario La Paz), C.A. Borghi(University of Bologna), Elvira L Massó-González(AstraZeneca (Spain)), Joep Perk(Linnaeus University), Eliseo Güallar(New York University), F. Jiménez, Jean Dallongeville(Inserm), Julian Halcox(Swansea University), G De Backer(Ghent University Hospital), Philippe Gabríel Steg(Mount Sinai Hospital)
Cited by 357
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k